Goldman Sachs Group Inc Nektar Therapeutics Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Nektar Therapeutics stock. As of the latest transaction made, Goldman Sachs Group Inc holds 710,306 shares of NKTR stock, worth $880,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
710,306
Previous 863,869 17.78%
Holding current value
$880,779
Previous $483,000 36.65%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.49 - $0.96 $75,245 - $147,420
-153,563 Reduced 17.78%
710,306 $660,000
Q4 2023

Feb 13, 2024
SELL
$0.42 - $0.57 $68,289 - $92,679
-162,595 Reduced 15.84%
863,869 $483,000
Q3 2023

May 14, 2024
BUY
$0.51 - $1.05 $82,923 - $170,724
162,595 Added 18.82%
1,026,464 $615,000
Q3 2023

Nov 14, 2023
SELL
$0.51 - $1.05 $140,711 - $289,700
-275,905 Reduced 21.18%
1,026,464 $615,000
Q2 2023

May 14, 2024
BUY
$0.53 - $1.03 $132,685 - $257,860
250,350 Added 23.8%
1,302,369 $755,000
Q2 2023

Aug 14, 2023
BUY
$0.53 - $1.03 $132,685 - $257,860
250,350 Added 23.8%
1,302,369 $755,000
Q1 2023

May 14, 2024
SELL
$0.64 - $3.15 $20,462 - $100,714
-31,973 Reduced 2.95%
1,052,019 $736,000
Q1 2023

May 11, 2023
SELL
$0.64 - $3.15 $20,462 - $100,714
-31,973 Reduced 2.95%
1,052,019 $736,000
Q4 2022

May 14, 2024
SELL
$2.03 - $4.28 $37,808 - $79,715
-18,625 Reduced 1.69%
1,083,992 $2.45 Million
Q4 2022

Feb 13, 2023
SELL
$2.03 - $4.28 $37,808 - $79,715
-18,625 Reduced 1.69%
1,083,992 $2.45 Million
Q3 2022

May 14, 2024
BUY
$3.04 - $5.14 $1.22 Million - $2.06 Million
400,734 Added 57.09%
1,102,617 $3.53 Million
Q3 2022

Nov 10, 2022
BUY
$3.04 - $5.14 $1.22 Million - $2.06 Million
400,734 Added 57.09%
1,102,617 $3.53 Million
Q2 2022

May 14, 2024
SELL
$3.17 - $6.17 $513,495 - $999,453
-161,986 Reduced 18.75%
701,883 $2.67 Million
Q2 2022

Aug 15, 2022
BUY
$3.17 - $6.17 $667,082 - $1.3 Million
210,436 Added 42.82%
701,883 $2.67 Million
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $356,304 - $1.18 Million
85,650 Added 21.11%
491,447 $2.65 Million
Q4 2021

Feb 14, 2022
SELL
$10.83 - $18.41 $579,762 - $985,542
-53,533 Reduced 11.65%
405,797 $5.48 Million
Q3 2021

Nov 10, 2021
BUY
$13.07 - $18.84 $6 Million - $8.65 Million
459,330 New
459,330 $8.25 Million

Others Institutions Holding NKTR

# of Institutions
128
Shares Held
111M
Call Options Held
150K
Put Options Held
4K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $232M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email